A mixture of U.S. Food and Drug Administration-approved monoaminergic drugs protects the retina from light damage in diverse models of night blindness

Authors

Henri Leinonen, University of California, Irvine
Elliot H. Choi, University of California, Irvine
Anthony Gardella, Case Western Reserve University
Vladimir J. Kefalov, Washington University School of Medicine in St. Louis
Krzysztof Palczewski, University of California, Irvine

Journal

Investigative ophthalmology & visual science

Publication Date

4-1-2019

Volume

60

Issue

5

First Page

1442

Last Page

1453

Document Type

Open Access Publication

DOI

10.1167/iovs.19-26560

Rights and Permissions

Henri Leinonen, Elliot H. Choi, Anthony Gardella, Vladimir J. Kefalov, Krzysztof Palczewski; A mixture of U.S. Food and Drug Administration–approved monoaminergic drugs protects the retina from light damage in diverse models of night blindness. Invest. Ophthalmol. Vis. Sci. 2019;60(5):1442-1453. doi: 10.1167/iovs.19-26560. This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Leinonen, Henri; Choi, Elliot H.; Gardella, Anthony; Kefalov, Vladimir J.; and Palczewski, Krzysztof, "A mixture of U.S. Food and Drug Administration-approved monoaminergic drugs protects the retina from light damage in diverse models of night blindness." Investigative ophthalmology & visual science. 60, 5. 1442 - 1453. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8132